Primary, systemic amyloidosis and the dermatologist: Where classic skin lesions may provide the clue for early diagnosis

Dermatology Online Journal

Volumn 11, Issue 1, 2005, Pages

  Silverstein, Sophie R ^a  

^a WHITTINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANTIINFECTIVE AGENT; COLCHICINE; CONGO RED; DIMETHYL SULFOXIDE; DIURETIC AGENT; MELPHALAN; PREDNISONE;

ALOPECIA; AMYLOIDOSIS; BONE MARROW BIOPSY; CLINICAL FEATURE; CLINICAL TRIAL; CONSULTATION; HEART DISEASE; HUMAN; IMMUNOELECTROPHORESIS; KIDNEY FAILURE; LYMPHADENOPATHY; MACROGLOSSIA; NAIL DYSTROPHY; NEEDLE BIOPSY; PROGNOSIS; PUNCH BIOPSY; REVIEW; SKIN BIOPSY; SKIN DEFECT; SKIN DISCOLORATION; STAINING; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; AGED; BIOPSY; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; MIDDLE AGED; SKIN DISEASE;

AGED; AMYLOIDOSIS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; HUMANS; MIDDLE AGED; SKIN DISEASES;

EID: 33745120884     PISSN: 10872108     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Kyle RA, Bayrd ED: Amyloidosis: Review of 236 Cases. Medicine 1975 Jul; 54 (4):271-99.
2. Henry RB 3rd et al: Vascular amyloid in a patient with multiple myeloma. J Am Acad Dermatol 1986 Aug;15(2 Pt 2):379-82.
3. Fanti PA et al: Nail changes as the first sign of systemic amyloidosis. Dermatologia 1991;183(1):44-6.
4. Wheeler GE, Barrows GH: Alopecia Universalis. A manifestation of occult amyloidosis and multiple myeloma. Arch Dermatol 1981 Dec;117(12):815-6.
5. Johnson TM et al: Bullous amyloidosis. Cutis 1989 Apr;43(4):346-52.
6. Breathnach SM: Amyloid and amyloidosis. J Am Acad Dermatol 1988 Jan;18(1 Pt 1):1-16.
7. Breathnach SM et al: Systemic amyloidosis with an underlying lymphoproliferative disorder. Report of a case in which nail involvement was a presenting feature. Clin Exp Dermatol 1979 Dec;4(4):495-9.
8. Wheeler GE, Barrows GH: Alopecia Universalis. A manifestation of occult amyloidosis and multiple myeloma. Arch Dermatol 1981 Dec;117(12):815-6.
9. Moreau P et al: Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients: Br J Haematol 1998 Jun;101(4):766-9.
10. Duston MA et al: Diagnosis of amyloidosis by abdominal fat pad aspiration. Analysis of four years' experience. Am J Med 1987 Mar;82(3):412-4.
11. Libbey CA et al: Use of abdominal fat pad aspirate in the diagnosis of systemic amyloidosis. Arch Int Med 1983 Aug;143(8):1549-52.
12. Blum A, Sohar E: The diagnosis of amyloidosis. Ancillary procedures. Lancet 1962 Apr;1(7232):721-3.
13. Kyle RA, Bayrd ED: Amyloidosis: Review of 236 Cases. Medicine 1975 Jul; 54(4):271-99.
14. Kyle RA, Bayrd ED: Amyloidosis: Review of 236 Cases. Medicine 1975 Jul; 54(4):271-99.
15. Duston MA et al: Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis. Arthritis Rheum 1980 Jan;32(1):82-5.
16. Kyle RA et al: A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone and colchicine. N Engl J Med 1997 Apr;336(17):1202-7.
17. Comenzo RL et al: Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light chain) amyloidosis: survival and responses in 25 patients. Blood 1998 May;91(10):3662-70.
18. Comenzo RL: Primary Systemic Amyloidosis. Curr Treat Options Oncol. 2000 Apr:1(1):83-9.
19. Kumar KS, Lefkowitch J, Russo MW, Hesdorffer C, Kinkhabwala M, Kapur S, Emond JC, Brown RS Jr: Successful sequential liver and stem cell transplantation for hepatic failure due to primary AL amyloidosis. Gastroenterology. 2002 Jun;122(7):2026-31.
20. Mohty M, Albat B, Fegueux N, Rossi JF: Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis. Leuk Lymphoma. 2001 Mar;41(1-2):221-3.
21. Nowak G, Westermark P, Wernerson A, Herlenius G, Sletten K, Ericzon BG. Liver transplantation as rescue treatment in a patient with primary AL kappa amyloidosis. Transpl Int. 2000;13(2):92-7.